By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.
We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.
We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.
Learn more about our Cardio Analysis Services
Experts in cardiac safety
Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.
Lisa oversees regulatory strategy and medical writing at Richmond Pharmacology, supporting the delivery of high-quality, compliant, and patient-focused clinical research.
Dr Ulrike Lorch MD, FRCA, FFPM Chief Medical Director and Founder
Dr Ulrike Lorch is a co-founder and Chief Medical Director of Richmond Pharmacology and Director of Human Pharmacology at the Faculty of Pharmaceutical Medicine.
Samarjit Singh BSC, MSc Director of Clinical Operations
Samarjit has been part of the Richmond Pharmacology team over 16 years, during which he held several positions, including his current role as Director of Clinical Operations.
Sandra Johnson BSC Director of Commercial Project Management
Bringing over 20 years of experience in the life science sector, including at Roche and Novartis, Sandra has an extensive understanding of clinical trials.
.svg){kind=small}
.svg)
-min.jpg)
.jpg)
